Consultations
Open consultations
-
31 March - 12 May 2021Under :Health security and infectious diseases
-
31 March - 28 April 2021Under :Scientific committees
-
21 January - 15 April 2021
More information on the revision of the EU blood and tissues and cells legislation, including the different steps of the initiative
Under :Blood, tissues, cells and organs -
21 January - 15 April 2021
More information on the revision of the EU blood and tissues and cells legislation, including the different steps of the initiative
Under :Blood, tissues, cells and organs
Closed consultations
-
10 - 19 March 2021Under: Medicinal products
-
27 January - 24 February 2021Under: Health security and infectious diseases
-
15 January - 11 February 2021Under: Cross-border healthcare
-
25 November 2020 - 06 January 2021
Based on the outcome of the evaluation of the medicines for rare diseases and children legislation, the Commission will examine the impacts of future policy options to update the legal framework on medicines for rare diseases and paediatric medicines. The first step is an inception impact assessment (roadmap).
The revision of the two legislations is also one of the actions of the EU Pharmaceutical Strategy.
Under: Medicinal products -
17 November - 14 December 2020
More information on the revision of the EU blood and tissues and cells legislation, including the different steps of the initiative
Under: Blood, tissues, cells and organs -
26 October - 07 December 2020Under: Scientific committees
-
23 October - 07 December 2020Under: Scientific committees
-
23 September - 26 October 2020Under: Scientific committees, Dialogue and collaboration
-
22 June - 22 July 2020Under: Medicinal products
-
16 June - 15 September 2020Under: Medicinal products
Pages
Latest updates
Related information